yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q39017592-AEE5CE93-D239-4A3A-B85C-53FCEEE6F723
Q39017592-AEE5CE93-D239-4A3A-B85C-53FCEEE6F723
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39017592-AEE5CE93-D239-4A3A-B85C-53FCEEE6F723
A cost-effectiveness analysis of lisdexamfetamine dimesylate in the treatment of adults with attention-deficit/hyperactivity disorder in the UK.
P2860
Q39017592-AEE5CE93-D239-4A3A-B85C-53FCEEE6F723
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39017592-AEE5CE93-D239-4A3A-B85C-53FCEEE6F723
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
29f1758e4d6f7ff56a0030f55e94e719f919f79f
P2860
A systematic review of the safety of lisdexamfetamine dimesylate.